AAAAAA

   
Results: 1-7 |
Results: 7
MANAGEMENT OF HYPERTENSION AND ITS SEQUELAE WITH ACE-INHIBITORS - BIOCHEMICAL, PHARMACOLOGICAL AND CLINICAL ASPECTS
Authors: RANGOONWALA B ROSENTHAL J
Citation: B. Rangoonwala et J. Rosenthal, MANAGEMENT OF HYPERTENSION AND ITS SEQUELAE WITH ACE-INHIBITORS - BIOCHEMICAL, PHARMACOLOGICAL AND CLINICAL ASPECTS, International journal of clinical practice, 52(7), 1998, pp. 492-500
RAMIPRIL AND FELODIPINE - A COMPARISON OF THE EFFICACY AND SAFETY OF MONOTHERAPY VERSUS COMBINATION THERAPY
Authors: POISSON P BAUER B SCHUELER E RANGOONWALA B
Citation: P. Poisson et al., RAMIPRIL AND FELODIPINE - A COMPARISON OF THE EFFICACY AND SAFETY OF MONOTHERAPY VERSUS COMBINATION THERAPY, Current medical research and opinion, 13(8), 1996, pp. 445-456
FIXED-DOSE COMBINATIONS OF ACE-INHIBITORS
Authors: RANGOONWALA B SCHULZ W BAUER B
Citation: B. Rangoonwala et al., FIXED-DOSE COMBINATIONS OF ACE-INHIBITORS, British journal of clinical practice, 50(8), 1996, pp. 454
EFFICACY OF RAMIPRIL VERSUS ENALAPRIL IN PATIENTS WITH MILD-TO-MODERATE ESSENTIAL-HYPERTENSION
Authors: YASKY J VERHO M ERASMUS TP LUUS HG ANGELA M GRANDIN L AKBARY MA RANGOONWALA B
Citation: J. Yasky et al., EFFICACY OF RAMIPRIL VERSUS ENALAPRIL IN PATIENTS WITH MILD-TO-MODERATE ESSENTIAL-HYPERTENSION, British journal of clinical practice, 50(6), 1996, pp. 302
PHARMACOKINETICS, METABOLISM AND BILIARY AND URINARY-EXCRETION OF ORAL RAMIPRIL IN MAN
Authors: VERHO M LUCK C STELTER WJ RANGOONWALA B BENDER N
Citation: M. Verho et al., PHARMACOKINETICS, METABOLISM AND BILIARY AND URINARY-EXCRETION OF ORAL RAMIPRIL IN MAN, Current medical research and opinion, 13(5), 1995, pp. 264-273
STUDY OF THE EFFICACY AND SAFETY OF THE COMBINATION RAMIPRIL 2.5-MG PLUS HYDROCHLOROTHIAZIDE 12.5-MG IN PATIENTS WITH MILD-TO-MODERATE HYPERTENSION
Authors: GENTHON R RANGOONWALA B ANDRIEUXLACLAVELINE A ARNAUD J BALLADE M BILLOU J BOSREDON A BOUTGES B DUBON T GOIGOUX B LALANNE G LAURENTJOYE F LION A LORANS P MAURAT X MOULINET P RICARD L ROCHE A SDRIGOTTI D SDRIGOTTI J BUGNON P DELOGE J GENIN M JACSON P LAMIZET P MOURAUX J STRAUSS P TAQUE R VINCENT J BOULEN Y BOYAVAL B DANDOY P DELESCLUSE D DENIS X DERMAUT G DEROIDE F GHIENNE JP HERMEL R JAILLARD T MANIGLIER G MEURISSE F RICHARD G TIBERGHIEN P VANDENDRIESSCHE P VANNIER P AGNIEL P ARMAND C BOICHON P BOULE G CHAPPUY D CORMARY M DUMORTIER J DURAND JY GUEZ C HOBEIKA A HUCHON J LEAMMER G LAFUMA G LEVRAT P MEDIONI J MORIN MM CASABIANCACHICKLY M CECILE A DEREGIS H DESENCLOS J LEMIERE JM OVANON G RAINITSIMBA M RECORBET G ROBIN P ZINI G BAUMANN M BOCCARA J COUDRY A DIETRICH J FROIDEVAUX J KENTZINGER J MEYER P NEFF G PICA D ROBERT J VOGT P COZIC J DAHAN G DARTIGE JJ ELKOURI J EOCHE R FORTIS A GOURE P HAMEL NH LECOY C MANSEAU J PERIMONY C PIQUET P PONTONNIER J SUPIOT JL BENDAVID N BERGER P COLETTI M HADJADJ P HOLSTEIN M ROUGERON C SERERO A ANDRES F ATTUIL R BEFORT A BIDET P BIRRY G GUY I HARTMANN G SCHLEWITZ T COCHET D COGNEAU J CONAN M FITOUSSI W GIACOMINO A LEBLEU P LECALIER A LIARD F PALEOLOGUE F PERSONNIC S ROFFAY J SALMON T SERRE C THIMEL S BAUER B LENDRESSE P CARCONE N DELMAS F DENAES R SADORGE C DEROBERT E LEMARIE JC THEOBALD KH BOURDEREAU G IROUDAYASSAMY R SAMSONTHOMAS L FRAMPTON H CARRE A FILLASTRE JP GALLET M IMBS JL PLOUIN PF
Citation: R. Genthon et al., STUDY OF THE EFFICACY AND SAFETY OF THE COMBINATION RAMIPRIL 2.5-MG PLUS HYDROCHLOROTHIAZIDE 12.5-MG IN PATIENTS WITH MILD-TO-MODERATE HYPERTENSION, International journal of clinical pharmacology research, 14(1), 1994, pp. 1-9
MULTIPLE-DOSE PHARMACOKINETICS OF RAMIPRIL IN PATIENTS WITH CHRONIC CONGESTIVE-HEART-FAILURE
Authors: HEINTZ B VERHO M BROCKMEIER D LUCKEL G MAIGATTER S SIEBERTH HG RANGOONWALA B BENDER N
Citation: B. Heintz et al., MULTIPLE-DOSE PHARMACOKINETICS OF RAMIPRIL IN PATIENTS WITH CHRONIC CONGESTIVE-HEART-FAILURE, Journal of cardiovascular pharmacology, 22, 1993, pp. 190000036-190000042
Risultati: 1-7 |